Clinical Trial Update: Double Blind Randomized Trial to Compare Gurmar (Gymnema Sylvestre) With Metformin in Type 2 Diabetes [NA]

View source ↗

Summary

A double-blind randomized trial is comparing Gurmar (Gymnema sylvestre) with Metformin for Type 2 Diabetes; the current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Gurmar (Gymnema sylvestre)
• metformin (metformin)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Type 2 Diabetes Mellitus | NA | Status: UNKNOWN